ExpertLungDx
Chronic Lung Diseases (COPD, Asthma, Pulmonary Hypertension, Interstitial Lung Disease)
Pre-clinicalActive
Key Facts
Indication
Chronic Lung Diseases (COPD, Asthma, Pulmonary Hypertension, Interstitial Lung Disease)
Phase
Pre-clinical
Status
Active
Company
About Metfora
Metfora is an early-stage diagnostics company founded in 2021 and based in Cambridge, Massachusetts. It is developing a blood-based metabolomic test designed to detect serious chronic diseases, such as COPD and pulmonary hypertension, at early stages using a proprietary metabolite analysis platform. The company has initiated regulatory discussions with the FDA for its lead test, ExpertLungDx, targeting a significant unmet need in reducing diagnostic delays. Its business model is centered on providing actionable diagnostic insights to healthcare providers and systems.
View full company profile